Transforming screening, diagnosis and treatment of prostate cancer
Hashim is currently Chair of Urology and Head of the Section of Specialty Surgery at Imperial College London which incorporates breast, ENT, head and neck, neurosurgery, ophthalmology, urology and vascular surgery. He heads up the Imperial Prostate group since 2017 when he took up the Chair of Urology having previously been at UCL as a MRC Clinical Research Training Fellow for his PhD, followed by an MRC Clinician Scientist Fellowship which incorporated his position as Clinical Senior Lecturer and then Reader in Urology. He currently holds a Wellcome Senior Research Fellowship (2017 to 2027). His research interests are in health technology assessment with a strong focus on clinical trials that bring innovative and transformative changes to the prostate cancer pathway from screening through to treatment of advanced disease. This has been and is supported by a grant income over the last 10 years of approximately £30M as lead applicant and £12M as co-applicant. He has well over 400 peer reviewed publications. He is active clinically, dealing with benign and malignant diseases of the prostate within the outpatient setting and operatively with minimally invasive approaches. As a result, he has and continues to train and support numerous urologists internationally in the specialised techniques that he has pioneered.

Please email Louise King ( if you would like to attend online.
Date: 24 May 2024, 8:00 (Friday, 5th week, Trinity 2024)
Venue: John Radcliffe Academic, Headington OX3 9DU
Venue Details: Lecture Theatre 1, and also online via Microsoft Teams
Speaker: Professor Hashim U. Ahmed (Imperial College London)
Organising department: Nuffield Department of Surgical Sciences
Organiser: Tarryn Ching (University of Oxford, Nuffield Department of Surgical Sciences)
Part of: Surgical Grand Rounds
Booking required?: Not required
Audience: Members of the University only
Editor: Louise King